A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia
暂无分享,去创建一个
R. Romero | S. Hassan | O. Erez | T. Chaiworapongsa | A. Conde-Agudelo | F. Gotsch | S. Mazaki‐Tovi | L. Yeo | J. Kusanovic | E. Vaisbuch | P. Mittal | R. Gomez | S. Edwin | A. CONDE-AGUDELO
[1] H. Meiri,et al. Placental Protein 13 as an Early Marker for Preeclampsia: A Prospective Longitudinal Study , 2009 .
[2] Roberto Romero,et al. Prenatal medicine: The child is the father of the man* , 2009, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[3] James M. Roberts. 8: A randomized controlled trial of antioxidant vitamins to prevent serious complications associated with pregnancy related hypertension in low risk, nulliparous women , 2008 .
[4] H. Meiri,et al. Placental protein 13 as an early marker for pre‐eclampsia: a prospective longitudinal study * , 2008, BJOG : an international journal of obstetrics and gynaecology.
[5] K. Nicolaides,et al. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre‐eclampsia , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[6] K. Spencer,et al. Maternal serum inhibin‐A and activin‐A levels in the first trimester of pregnancies developing pre‐eclampsia , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[7] B. Sibai,et al. Serum inhibin A and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia? , 2008, American journal of obstetrics and gynecology.
[8] N. Bersinger,et al. First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia. , 2008, American journal of obstetrics and gynecology.
[9] R. Levine,et al. Circulating soluble endoglin and placental abruption , 2008, Prenatal diagnosis.
[10] A. Diab,et al. Angiogenic factors for the prediction of pre‐eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry , 2008, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[11] K. Nicolaides,et al. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre‐eclampsia , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[12] H. Cuckle,et al. First-trimester maternal serum PP13 in the risk assessment for preeclampsia. , 2008, American journal of obstetrics and gynecology.
[13] F. Corrado,et al. Endoglin, PlGF and sFlt‐1 as markers for predicting pre‐eclampsia , 2008, Acta obstetricia et gynecologica Scandinavica.
[14] B. Thilaganathan,et al. First‐trimester uterine artery Doppler indices in term and preterm pre‐eclampsia , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[15] S. Y. Park,et al. Effective Prediction of Preeclampsia by a Combined Ratio of Angiogenesis-Related Factors , 2008, Obstetrics and gynecology.
[16] E. Gratacós,et al. Predictive value of angiogenic factors and uterine artery Doppler for early‐ versus late‐onset pre‐eclampsia and intrauterine growth restriction , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[17] N. Wessel,et al. Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion. , 2008, American journal of obstetrics and gynecology.
[18] K. Nicolaides,et al. Low levels of maternal serum PAPP‐A in the first trimester and the risk of pre‐eclampsia , 2008, Prenatal diagnosis.
[19] S. Andrade,et al. Placental Growth Factor (PlGF) Is a Surrogate Marker in Preeclamptic Hypertension , 2008, Hypertension in pregnancy.
[20] Wenjiang J. Fu,et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate , 2008, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[21] R. Romero,et al. The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation , 2008, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[22] Wenjiang J. Fu,et al. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age , 2008, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[23] K. Nicolaides,et al. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre‐eclampsia , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[24] N Stephen Pollitt,et al. Recombinant Vascular Endothelial Growth Factor 121 Attenuates Hypertension and Improves Kidney Damage in a Rat Model of Preeclampsia , 2007, Hypertension.
[25] S. Crawford,et al. Angiogenic factors for the prediction of preeclampsia in high-risk women. , 2007, American journal of obstetrics and gynecology.
[26] E. R. Unal,et al. Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia. , 2007, American journal of obstetrics and gynecology.
[27] S. Karumanchi,et al. Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia. , 2007, American journal of obstetrics and gynecology.
[28] Donna D. Johnson,et al. Soluble endoglin as a second-trimester marker for preeclampsia. , 2007, American journal of obstetrics and gynecology.
[29] K. Lim,et al. Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy. , 2007, American journal of obstetrics and gynecology.
[30] M. Wolf,et al. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. , 2007, American journal of obstetrics and gynecology.
[31] D. Haidopoulos,et al. Screening for pre‐eclampsia and small for gestational age fetuses at the 11–14 weeks scan by uterine artery Dopplers , 2007, Acta obstetricia et gynecologica Scandinavica.
[32] H. Stepan,et al. Cytomegalovirus-induced mirror syndrome associated with elevated levels of angiogenic factors. , 2007, Obstetrics and gynecology.
[33] R. Romero,et al. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. , 2007, American journal of obstetrics and gynecology.
[34] N. Wessel,et al. Predictive Value of Maternal Angiogenic Factors in Second Trimester Pregnancies With Abnormal Uterine Perfusion , 2007, Hypertension.
[35] L. Zou,et al. [Predictive value of soluble vascular endothelial growth factor receptor 1 for preeclampsia in second-trimester]. , 2007, Zhonghua fu chan ke za zhi.
[36] L. Vatten,et al. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia. , 2007, American journal of obstetrics and gynecology.
[37] E. Chien,et al. Cytomegalovirus-Induced Mirror Syndrome Associated With Elevated Levels of Circulating Antiangiogenic Factors , 2007, Obstetrics and gynecology.
[38] Mitsuaki Suzuki,et al. Alterations in Placental Growth Factor Levels before and after the Onset of Preeclampsia Are More Pronounced in Women with Early Onset Severe Preeclampsia , 2007, Hypertension Research.
[39] K. Spencer,et al. First‐trimester maternal serum PP‐13, PAPP‐A and second‐trimester uterine artery Doppler pulsatility index as markers of pre‐eclampsia , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[40] P. Antsaklis,et al. Screening for pre‐eclampsia and fetal growth restriction by uterine artery Doppler and PAPP‐A at 11–14 weeks' gestation , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[41] R. Romero,et al. Unexplained fetal death: Another anti-angiogenic state , 2007, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[42] R. Levine,et al. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. , 2006, Hypertension.
[43] A. Hingorani,et al. Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction. , 2006, American journal of obstetrics and gynecology.
[44] B. Sibai,et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. , 2006, The New England journal of medicine.
[45] F. Epstein,et al. Circulating Angiogenic Factors and Placental Abruption , 2006, Obstetrics and gynecology.
[46] Ling Liu,et al. [Predictive value of serum soluble fms-like tyrosine kinase 1 concentration in preeclampsia at second trimester]. , 2006, Zhonghua fu chan ke za zhi.
[47] Donna D. Johnson,et al. Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. , 2006, American journal of obstetrics and gynecology.
[48] E. Gratacós,et al. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. , 2006, American journal of obstetrics and gynecology.
[49] T. Libermann,et al. Soluble endoglin contributes to the pathogenesis of preeclampsia , 2006, Nature Medicine.
[50] H. Stepan,et al. Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops. , 2006, The New England journal of medicine.
[51] Caroline A Crowther,et al. Spontaneous preterm delivery in primiparous women at low risk in Denmark: population based study , 2006, BMJ : British Medical Journal.
[52] L. Poston,et al. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial , 2006, The Lancet.
[53] D. Hassiakos,et al. Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates. , 2006, Early human development.
[54] F. Epstein,et al. Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women. , 2006, American journal of obstetrics and gynecology.
[55] V. Jha,et al. Low urinary placental growth factor is a marker of pre-eclampsia. , 2006, Kidney international.
[56] H. Masuyama,et al. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis. , 2006, American journal of obstetrics and gynecology.
[57] G. Dekker,et al. Circulating Angiogenic Factors and Abnormal Uterine Artery Doppler Velocimetry in the Second Trimester , 2006, Hypertension in pregnancy.
[58] K. Nicolaides,et al. A novel approach to first‐trimester screening for early pre‐eclampsia combining serum PP‐13 and Doppler ultrasound , 2005, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[59] R. Romero,et al. A role of the anti-angiogenic factor sVEGFR-1 in the ‘mirror syndrome’ (Ballantyne's syndrome) , 2005, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[60] G. Creatsas,et al. Vascular Endothelial Growth Factor and Placenta Growth Factor in Intrauterine Growth-Restricted Fetuses and Neonates , 2005, Mediators of inflammation.
[61] R. Rodrigo,et al. Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. , 2005, American journal of obstetrics and gynecology.
[62] R. Romero,et al. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia. , 2005, American journal of obstetrics and gynecology.
[63] T. Lyberg,et al. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. , 2005, European journal of obstetrics, gynecology, and reproductive biology.
[64] B. Sachs,et al. Recent advances in understanding of preeclampsia. , 2005, Croatian medical journal.
[65] Kypros H Nicolaides,et al. An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. , 2005, American journal of obstetrics and gynecology.
[66] R. Ness,et al. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. , 2005, The Journal of clinical endocrinology and metabolism.
[67] M. Wolf,et al. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women. , 2005, Placenta.
[68] I. Sargent,et al. Latest Advances in Understanding Preeclampsia , 2005, Science.
[69] R. Levine,et al. Circulating Angiogenic Factors in Preeclampsia , 2005, Clinical obstetrics and gynecology.
[70] H. Uzun,et al. Prediction of preeclampsia with maternal mid‐trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry , 2005, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[71] S. Maynard,et al. Soluble Fms-like Tyrosine Kinase 1 and Endothelial Dysfunction in the Pathogenesis of Preeclampsia , 2005, Pediatric Research.
[72] L. Regan,et al. Term preeclampsia is associated with minimal histopathological placental features regardless of clinical severity , 2005, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.
[73] R. Romero,et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia , 2005, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[74] A. Hunter,et al. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. , 2004, American journal of obstetrics and gynecology.
[75] G. PaolaViviani,et al. Curva nacional de distribución de peso al nacer según edad gestacional: Chile, 1993 a 2000 , 2004 .
[76] N. Berkane,et al. Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia. , 2004, Clinical chemistry.
[77] K. Nicolaides,et al. The role of uterine artery Doppler in predicting adverse pregnancy outcome. , 2004, Best practice & research. Clinical obstetrics & gynaecology.
[78] R. Romero,et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. , 2004, American journal of obstetrics and gynecology.
[79] M. Wolf,et al. Differential risk of hypertensive disorders of pregnancy among Hispanic women. , 2004, Journal of the American Society of Nephrology : JASN.
[80] K. Lim,et al. Circulating angiogenic factors and the risk of preeclampsia. , 2004, The New England journal of medicine.
[81] Robert N. Taylor,et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. , 2004, The Journal of clinical endocrinology and metabolism.
[82] L. Vatten,et al. Pre-eclampsia: associated with increased syncytial apoptosis when the infant is small-for-gestational-age. , 2004, Journal of reproductive immunology.
[83] F. Prefumo,et al. Effect of parity on second‐trimester uterine artery Doppler flow velocity and waveforms , 2004, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[84] H. Augustin,et al. Prospective Analysis of Placenta Growth Factor (PlGF) Concentrations in the Plasma of Women with Normal Pregnancy and Pregnancies Complicated by Preeclampsia , 2004, Hypertension in pregnancy.
[85] J. Foidart,et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. , 2003, The Journal of clinical endocrinology and metabolism.
[86] B. Sibai,et al. The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. , 2003, American journal of obstetrics and gynecology.
[87] T. Libermann,et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. , 2003, The Journal of clinical investigation.
[88] I. Sargent,et al. Trophoblast deportation and the maternal inflammatory response in pre-eclampsia. , 2003, Journal of reproductive immunology.
[89] D. Saller,et al. Second‐Trimester Maternal Serum Placental Growth Factor and Vascular Endothelial Growth Factor for Predicting Severe, Early‐Onset Preeclampsia , 2003, Obstetrics and gynecology.
[90] C. Schmitz,et al. Pre-eclampsia and maternal anaemia display reduced apoptosis and opposite invasive phenotypes of extravillous trophoblast. , 2003, Placenta.
[91] Y. Taketani,et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. , 2003, The Journal of clinical endocrinology and metabolism.
[92] I. Crocker,et al. Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction. , 2003, The American journal of pathology.
[93] J. Brosens,et al. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. , 2002, American journal of obstetrics and gynecology.
[94] L. Myatt. Role of placenta in preeclampsia , 2002, Endocrine.
[95] M. Elwood. Proteomic patterns in serum and identification of ovarian cancer , 2002, The Lancet.
[96] B. Rockhill. Proteomic patterns in serum and identification of ovarian cancer , 2002, The Lancet.
[97] N. Anim-Nyame,et al. Does endothelial cell activation occur with intrauterine growth restriction? , 2002, BJOG : an international journal of obstetrics and gynaecology.
[98] L. Poston,et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. , 2002, American journal of obstetrics and gynecology.
[99] J. Granger,et al. Pathophysiology of Preeclampsia: Linking Placental Ischemia/Hypoxia with Microvascular Dysfunction , 2002, Microcirculation.
[100] J. Roberts,et al. Recent Insights into the pathogenesis of pre-eclampsia. , 2002, Placenta.
[101] Diagnosis and management of preeclampsia and eclampsia , 2002 .
[102] E. Petricoin,et al. Use of proteomic patterns in serum to identify ovarian cancer , 2002, The Lancet.
[103] S. Cicero,et al. Second-trimester uterine artery Doppler screening in unselected populations: a review , 2002, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[104] A. Blann,et al. Maternal endothelial soluble cell adhesion molecules with isolated small for gestational age fetuses: comparison with pre‐eclampsia , 2001, BJOG : an international journal of obstetrics and gynaecology.
[105] S. Cicero,et al. Screening for pre‐eclampsia and fetal growth restriction by uterine artery Doppler at 11–14 weeks of gestation , 2001, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[106] K. Nicolaides,et al. Multicenter screening for pre‐eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation , 2001, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[107] C. Oudejans,et al. Plasma Placenta Growth Factor Levels in Midtrimester Pregnancies , 2001, Obstetrics and gynecology.
[108] S. Chow,et al. Decreased Maternal Serum Placenta Growth Factor in Early Second Trimester and Preeclampsia , 2001, Obstetrics and gynecology.
[109] J. Aarnoudse,et al. Uterine artery Doppler flow and uteroplacental vascular pathology in normal pregnancies and pregnancies complicated by pre-eclampsia and small for gestational age fetuses. , 2001, Placenta.
[110] D. Sahota,et al. Increased placental apoptosis in pregnancies complicated by preeclampsia. , 2001, American journal of obstetrics and gynecology.
[111] H. Ho,et al. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. , 2001, American journal of obstetrics and gynecology.
[112] B. Sibai,et al. Placenta growth factor is not an early marker for the development of severe preeclampsia. , 2001, American journal of obstetrics and gynecology.
[113] C. Berg,et al. Pregnancy‐Related Mortality From Preeclampsia and Eclampsia , 2001, Obstetrics and gynecology.
[114] L. Poston,et al. Is oxidative stress involved in the aetiology of pre‐eclampsia? , 2001, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[115] L. Vatten,et al. Preeclampsia and Fetal Growth , 2000, Obstetrics and gynecology.
[116] K. Nicolaides,et al. One‐Stage Screening for Pregnancy Complications by Color Doppler Assessment of the Uterine Arteries at 23 Weeks' Gestation , 2000, Obstetrics and gynecology.
[117] A. Duits,et al. Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia. , 2000, British journal of obstetrics and gynaecology.
[118] R. North,et al. Mid‐trimester uterine artery Doppler screening as a predictor of adverse pregnancy outcome in high‐risk women , 2000, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[119] M. Faas,et al. Etiology and pathogenesis of preeclampsia: current concepts. , 1999, American journal of obstetrics and gynecology.
[120] I. Sargent,et al. Trophoblast deportation in human pregnancy--its relevance for pre-eclampsia. , 1999, Placenta.
[121] T. H. Wang,et al. Preeclampsia is associated with reduced serum levels of placenta growth factor. , 1998, American journal of obstetrics and gynecology.
[122] G. Mires,et al. Assessment of uterine arterial notching as a screening test for adverse pregnancy outcome. , 1998, American journal of obstetrics and gynecology.
[123] I. Sargent,et al. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre‐eclamptic pregnancies , 1998, British journal of obstetrics and gynaecology.
[124] J. Roberts,et al. Endothelial Dysfunction in Preeclampsia , 1998, Seminars in reproductive endocrinology.
[125] A. Many,et al. Vascular Endothelial Growth Factor Is Increased in Patients With Preeclampsia , 1997, American journal of reproductive immunology.
[126] I. Greer,et al. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre‐eclampsia , 1997, British journal of obstetrics and gynaecology.
[127] C. Lees,et al. Doppler ultralsound of the uterine arteries: the importance of bilateral notching in the prediction of pre‐eclampsia, placental abruption or delivery of a small‐for‐gestational‐age baby , 1996 .
[128] N. Suehara,et al. Uterine Artery Doppler Velocimetry in Relation to Trophoblast Migration into the Myometrium of the Placental Bed , 1995, Obstetrics and gynecology.
[129] S. Campbell,et al. Doppler ultrasound screening as part of routine antenatal scanning: Prediction of pre‐eclampsia and intrauterine growth retardation , 1994, British journal of obstetrics and gynaecology.
[130] R. Pijnenborg,et al. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre‐eclamptic pregnancies , 1994, British journal of obstetrics and gynaecology.
[131] S. Bewley,et al. Improved prediction of preeclampsia by two‐stage screening of uterine arteries using the early diastolic notch and color Doppler imaging , 1993, Obstetrics and gynecology.
[132] K. Maršál,et al. A high uterine artery pulsatility index reflects a defective development of placental bed spiral arteries in pregnancies complicated by hypertension and fetal growth retardation. , 1993, European journal of obstetrics, gynecology, and reproductive biology.
[133] F. Epstein,et al. Plasma endothelin levels in preeclampsia: Elevation and correlation with uric acid levels and renal impairment , 1992, American journal of obstetrics and gynecology.
[134] S. Bewley,et al. Doppler velocimetry studies of the uterine artery in the early prediction of pre-eclampsia and intra-uterine growth retardation. , 1991, European journal of obstetrics, gynecology, and reproductive biology.
[135] I. Sargent,et al. Trophoblast deportation in pre‐eclamptic pregnancy , 1991, British journal of obstetrics and gynaecology.
[136] R. Pijnenborg,et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy , 1991, British journal of obstetrics and gynaecology.
[137] T. Musci,et al. Preeclampsia: an endothelial cell disorder. , 1989, American journal of obstetrics and gynecology.
[138] F. de Wolf,et al. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. , 1987, British journal of obstetrics and gynaecology.
[139] T. Khong,et al. Inadequate maternal vascular response to placentation in pregnancies complicated by pre‐eclampsia and by small‐for‐gestational age infants , 1986 .
[140] M. J. Teague,et al. NEW DOPPLER TECHNIQUE FOR ASSESSING UTEROPLACENTAL BLOOD FLOW , 1983, The Lancet.
[141] J. Bonnar,et al. An ultrastructural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation. , 1982, British journal of obstetrics and gynaecology.
[142] F. de Wolf,et al. Fetal growth retardation and the maternal arterial supply of the human placenta in the absence of sustained hypertension. , 1981, British journal of obstetrics and gynaecology.
[143] I. Brosens,et al. FETAL GROWTH RETARDATION AND THE MATERNAL ARTERIAL SUPPLY OF THE HUMAN PLACENTA IN THE ABSENCE OF SUSTAINED HYPERTENSION , 1980 .
[144] I. Brosens. Morphological changes in the utero-placental bed in pregnancy hypertension. , 1977, Clinics in obstetrics and gynaecology.
[145] W. B. Robertson,et al. FETAL GROWTH RETARDATION AND THE ARTERIES OF THE PLACENTAL BED , 1977, British journal of obstetrics and gynaecology.
[146] Wenjiang J. Fu,et al. THE CHANGE IN CONCENTRATIONS OF ANGIOGENIC AND ANTI-ANGIOGENIC FACTORS IN MATERNAL PLASMA BETWEEN THE FIRST AND SECOND TRIMESTERS IN RISK ASSESSMENT FOR THE SUBSEQUENT DEVELOPMENT OF PREECLAMPSIA AND SGA , 2010 .
[147] M. Beckmann,et al. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. , 2007, Clinical science.
[148] U. Stenman,et al. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation. , 2006, The Journal of clinical endocrinology and metabolism.
[149] P. Bossuyt,et al. World Health Organization systematic review of screening tests for preeclampsia. , 2005, Obstetrics and gynecology.
[150] R. Gomez,et al. [A national birth weight distribution curve according to gestational age in Chile from 1993 to 2000]. , 2004, Revista medica de Chile.
[151] Robert N. Taylor,et al. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. , 2003, American journal of obstetrics and gynecology.
[152] H. Matsuo,et al. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. , 2002, American journal of obstetrics and gynecology.
[153] C. O'Herlihy,et al. Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance. , 2001, American journal of obstetrics and gynecology.
[154] Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. , 2000, American journal of obstetrics and gynecology.
[155] K. Lim,et al. Circulating Factors as Markers and Mediators of Endothelial Cell Dysfunction in Preeclampsia , 1998, Seminars in reproductive endocrinology.
[156] E. Steegers,et al. Plasma glutathion S-transferase-Alpha levels in preeclampsia and HELLP syndrome , 1996 .
[157] V. Becker,et al. Doppler flow measurements and histomorphology of the placental bed in uteroplacental insufficiency , 1992, Journal of perinatal medicine.
[158] W. B. Robertson,et al. Maternal uterine vascular lesions in the hypertensive complications of pregnancy. , 1976, Perspectives in nephrology and hypertension.
[159] W. B. Robertson,et al. The role of the spiral arteries in the pathogenesis of preeclampsia. , 1972, Obstetrics and gynecology annual.